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Abstract
Background and study aims: Small intestinal ischemia-reperfusion (IR) is a frequent, potentially life threatening
phenomenon. There is a lack of non-invasive diagnostic modalities. For many intestinal diseases, visualizing the intestinal
mucosa using endoscopy is gold standard. However, limited knowledge exists on small intestinal IR-induced, early mucosal
changes. The aims of this study were to investigate endoscopic changes in human jejunum exposed to IR, and to study
concordance between endoscopic appearance and histology.
Patients and methods: In 23 patients a part of jejunum, to be removed for surgical reasons, was isolated and selectively
exposed to ischemia with 0, 30 or 120 minutes of reperfusion. In 3 patients, a videocapsule was inserted in the isolated
segment before exposure to IR, to visualize the mucosa. Endoscopic view at several time points was related to histology
(Heamatoxylin & Eosin) obtained from 20 patients.
Results: Ischemia was characterized by loss of villous structure, mucosal whitening and appearance of punctate lesions. This
was related to appearance of subepithelial spaces and breaches in the epithelial lining in the histological view. Early during
reperfusion, the lumen filled with IR-damaged, shed cells and VCE showed mucosal erosions, hemorrhage and intraluminal
debris. At 60 minutes of reperfusion, the only remaining signs of IR were loss of villous structure and small erosions,
indicating rapid mucosal healing.
Conclusions: This study shows a unique, real-time in vivo endoscopic view of early mucosal changes during IR of the human
small intestine. Future studies should evaluate its usefulness in diagnosis of patients suspected of IR.
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Introduction
Small intestinal ischemia is a frequently occurring, life
threatening phenomenon. It arises from occlusion, vasospasms
and/or hypoperfusion of the mesenteric vasculature. Mortality
rates exceed 60% and have remained stable over the past decades.
[1,2] Mortality rates are linked to the development of transmural
damage, and translocation of bacteria to the circulation, causing
systemic inflammation and multiple organ failure. [3,4] In
addition, a variety of studies showed a link between intestinal IR
and the development of acute lung injury (ALI), which strongly
contributes to the high mortality. [5,6] Early recognition of
mesenteric ischemia has been shown to significantly improve
patient outcome, [7] however, timely decision making is challeng-
ing, since clinical presentation is often nonspecific and there is a
lack of diagnostic tests to assess intestinal damage. In addition,
diagnosis often requires invasive testing, including angiography,
exposing patients who typically have several comorbidities to risk.
[1,2].
Although colonoscopy has already been implemented in the
diagnostic workup of patients suspected of colonic ischemia, upper
endoscopy has little place in the diagnosis of small intestinal
ischemia. [8] One downside of upper endoscopy is that detection
of mesenteric ischemia is limited by the reach of the instrument,
which makes it difficult to trace ischemic areas in distal parts of the
small intestine. In contrast, chronic mesenteric ischemia often also
involves the proximal part of the small intestine, and recent
advances in endoscopic techniques such as visible light spectros-
copy, have been shown to be valuable in diagnosing chronic
mesenteric ischemia. [9,10] A second potential drawback of
gastrointestinal endoscopy in the detection of mesenteric ischemia,
is that endoscopists should avoid intraluminal pressures exceeding
30 mmHg, since this has been shown to decrease blood flow in the
small bowel and colon. [8,11] Moreover, care should be taken to
avoid overinflation or advancement of the scope beyond the
affected area to minimize the risk of bowel perforation.
An approach that could circumvent these problems is the use of
videocapsule endoscopy (VCE). Since the introduction of VCE by
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to non-invasively visualize the gastrointestinal mucosa in a variety
of diseases. In this study, we set out to investigate real-time in vivo
mucosal changes during the early phases of human small intestinal
ischemia-reperfusion, by using VCE technology in a newly
developed human experimental IR-model. [13,14] In addition,
we provide the relation between endoscopic view and histological
appearance of human jejunum exposed to IR.
Materials and Methods
Ethics
The study was approved by the Medical Ethical Committee of
Maastricht University Medical Center and was conducted
according to the revised version of the Declaration of Helsinki
(October 2008, Seoul). All patients were informed about the
experimental procedures and written informed consent of all
patients was obtained prior to the surgical procedure.
Patients and Surgical Procedures
Patients. 23 patients undergoing pancreatico-duodenectomy
were included in this study. VCE data were obtained from 3
patients included in our newly developed human intestinal IR
model, and VCE data were compared to histology from 20
patients included in the same human intestinal IR model.
Human intestinal IR protocol. The experimental protocol
was performed as previously described. [13,14] During pancrea-
tico-duodenectomy, a variable length of jejunum is routinely
resected in continuity with the head of the pancreas and
duodenum as part of the surgical procedure (Figure 1A). The
terminal 6 cm of this jejunal segment was isolated and subjected to
either 30 or 60 minutes of ischemia by placing two atraumatic
vascular clamps across the mesentery (30I: n=10, 60I: n=13, of
which 3 patients were included in the VCE protocol (see below)).
Meanwhile, surgery proceeded as planned. After ischemia, one
third (2 cm) of the isolated ischemic jejunum was resected using a
linear cutting stapler (GIA
TM, Covidien, Mansfield, MA). Next,
clamps were removed to allow reperfusion, as confirmed by
regaining of normal pink color and restoration of gut motility.
Another segment of the isolated jejunum (2 cm) was resected
similarly after 30 minutes of reperfusion, and 120 minutes of
reperfusion. Simultaneously, 2 cm of jejunum which remained
untreated during surgery was resected and served as internal
control tissue. Tissue samples were immediately formalin-fixed.
VCE protocol. To visualize the mucosa during IR, a small
bowel VC (Pillcam
TM-SB2, Given Imaging, Yokneam, Israel) was
insertedintheisolatedpartofintestineof3patients(2F:1M,meanage
64y),priortotheinductionofischemia(Figure1B).Thevideocapsule
wasinsertedviaasmallincision(seeFigure1B),andafterinsertionof
thecapsule, thepieceofjejunumwiththeincisionwasstapledoff, to
prevent any possible leakage of intraluminal content towards the
abdomen (see Figure 1B). After recording the endoscopic view of
healthymucosa,thehumanintestinalIRprocedurewasinitiated(see
detailed protocol above). VCE data were investigated using
RapidReader v6.3 software (Given Imaging), and endoscopic view
was captured at several time points (30I, 60I, 60I 30R, 60I .60R).
Macroscopicchangeswerecomparedtothehistologicalappearance
inHaematoxylin&Eosin(H&E)stainingfromjejunumexposedto30I
(n=10 patients, 7M:3F), or 60I with 0R, 30R and .60R (n=10
patients, 8M:2F). [14,15].
Histology
Tissuespecimensobtainedduringtheexperimentalprotocolwere
immediately immersed in 4% formaldehyde fixative (Unifix,
Klinipath, Duiven, the Netherlands) and incubated overnight at
room temperature. Next, tissue samples were embedded in paraffin
and 4 mm sections were cut. For morphological analysis, sections
were deparaffinized in xylene and rehydrated in graded ethanol to
distilled water and stained withHaematoxylin&Eosin (H&E).
Results
Human Intestinal Ischemia Induces Pale Discoloration of
the Mucosa and Small Punctate Lesions
Before induction of ischemia, jejunal mucosa appeared healthy
as indicated by the pink color and villous structure (Figure 2A).
H&E staining showed normal histological appearance (Figure 3A),
indicating good accordance between macroscopic view and
histology. During ischemia, the mucosa gradually became pale
(Figure 2B). The villous structure had disappeared at 30 minutes of
ischemia, although signs of macroscopic mucosal damage were
absent (Figure 2B1). At this point, histology showed retraction of
the basement membrane leading to subepithelial spaces
(Figure 3B), which might explain the loss of villous structure in
the endoscopic view. Even after 60 minutes of ischemia,
Figure 1. Human experimental model to study real time in vivo mucosal changes during human intestinal IR. (A) During a pylorus-
preserving pancreaticoduodenectomy, a part of otherwise healthy intestine is removed for surgical reasons. A small segment (red arrowhead) of
jejunum is isolated on both sides using a cutting stapler, allowing us to selectively expose it to ischemia and reperfusion. (B) Prior to induction of
ischemia, a small bowel videocapsule is introduced into the isolated part of intestine via a small incision and positioned at the distal end of the
isolated part of intestine (1 and 2). The part with the incision is resected using a cutting stapler (3), to rule out any possible leakage from intraluminal
content towards the abdominal cavity.
doi:10.1371/journal.pone.0039638.g001
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focal spots of hemorrhage within the white-appearing mucosa
(Figure 2B2). In histology, these punctate lesions appeared to arise
from detachment of epithelial sheets (Figure 3C).
Early Reperfusion of Ischemic Intestine is Associated with
Development of Intraluminal Debris, Mucosal Erosions
and Hemorrhage
To study the consequences of reperfusion of ischemic
jejunum, vascular clamps were removed after 60 minutes of
ischemia. Interestingly, the intestinal lumen rapidly filled with a
milky substance (Figure 2C), while the underlying mucosa
exhibited signs of erosion (Figure 2C). After 15–20 minutes of
reperfusion, the intraluminal debris was aspirated by needle
puncture of the intestinal segment to regain vision on the
mucosa. At this point, hemorrhage became apparent and large
regions showed loss of the typical small intestinal villous
structure (Figure 2D1). At 30 minutes of reperfusion, parts of
the mucosa had regained color, while sharply demarcated
regions showed superficial ulceration and hemorrhage
(Figure 2D2). White ‘clouds’ of intraluminal debris were
observed, which represented shed IR-damaged cells together
with fluids and blood in H&E staining (Figure 3D). [16].
IR-damaged Mucosa is Rapidly Restored during
Reperfusion
Remarkably, this heavily damaged mucosa recovered rapidly,
since within 45 minutes of reperfusion, the areas with hemorrhage
and erosions were reduced (Figure 2E), and after 60 minutes of
reperfusion the mucosa had regained its initial color (Figure 2F).
The remaining signs of ischemia were small erosions, spots with
hemorrhage, intraluminal debris, and loss of villous structure
(Figure 2F). Histologically, villi were strongly reduced in length. In
addition, the epithelial lining was recovering in most of the villi,
while IR-damaged shed epithelial cells were observed in the
intestinal lumen (Figure 3E).
Discussion
In this study, VCE was used in a recently developed human
experimental IR model, to visualize for the first time the early
mucosal changes during IR in man. First, this study demonstrates
that mucosal changes in the early phase of intestinal ischemia can
be limited to a pale discoloration of the mucosa, with appearance
of small punctate lesions when ischemia progresses. Second, we
show that mucosal IR-induced damage occurs particularly during
the reperfusion phase. Third, we show that the human small
intestine has a remarkable capacity to recover from ischemia, since
remaining signs of ischemia at 60 minutes of reperfusion were
limited to loss of villous structure, small erosions, and presence of
intraluminal debris.
In recent years, VCE is increasingly used for non-invasive
detection of mucosal pathology throughout the whole intestinal
tract. [17] In two case reports, VCE was successfully used to
detect acute mesenteric ischemia with bowel necrosis, [18] and
diffuse ischemia in a patient with Wegener’s granulomatosis.
[19] In both these cases, ischemia was characterized by
Figure 2. Endoscopic appearance of human jejunum exposed to IR. (A) Normal endoscopic appearance of control tissue (B1) Pale
discoloration of jejunal mucosa after 30 minutes of ischemia (B2) Appearance of small punctate lesions (white arrows) within the pale mucosa at 60
minutes of jejunal ischemia. (C) Within a few minutes of reperfusion, the intestinal lumen fills with a white substance (white arrowhead). (D1–D2) At
20–30 minutes of reperfusion, villous architecture in the mucosa is loss, and areas with hemorrhage (black arrows) and superficial erosions become
apparent. Note the ‘white clouds’ of debris in the intestinal lumen (white arrows). (E) At 45 minutes of reperfusion, areas with hemorrhage and
erosion are reduced. (F) At 60 minutes of reperfusion, the mucosa regained its initial color. Remaining signs of ischemia are the spots with
hemorrhage, the intraluminal debris (white arrow), and loss of the villous structure.
doi:10.1371/journal.pone.0039638.g002
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areas. Here, we show that VCE can also detect very early IR-
induced changes to the small intestinal mucosa, which are
mainly characterized by whitening of the mucosa and appear-
ance of small punctate lesions. This suggests that VCE could
help in decision making during the diagnostic workup.
Moreover, VCE could be useful to localize ischemia in parts
of the intestine that are difficult to visualize with routine
endoscopy, which could be used in guiding the surgeon to
surgical intervention. However, the limited changes during early
ischemia emphasize the importance of clinical suspicion and
alertness during endoscopy/VCE in patients.
Next to the mucosal changes following ischemia, we
demonstrate that reperfusion is associated with massive mucosal
damage to the epithelial lining. Previous studies have also
shown that on a histological level, reperfusion of ischemic
intestine causes massive cell shedding at the villus tips.
[16,20,21] In addition, the reperfusion phase was associated
with apoptosis of specialized Paneth cells in the crypts, [14]
which play a role in immunological intestinal barrier function.
Both these events facilitate bacterial translocation and inflam-
mation, [14,21] and it is therefore important to bear in mind
that, although rapid restoration of the blood flow is imperative
to improve patient outcome, reperfusion paradoxically induces
extensive intestinal barrier loss.
In addition to the death cells that are observed in the
intraluminal ‘milky’ substance, it is also likely that this substance
contains mucus, either secreted from goblet cells, or as a
consequence of goblet cell loss. We have recently shown that
ischemia with and without reperfusion in the human and rat colon
is associated with detachment of the mucus layer from the
epithelium and increased secretion of goblet cell mucus into the
intestinal lumen. [22] The rapid increase in intraluminal mucus
contents, accompanied by the hemorrhage as observed in this
study, explains why patients suffering from intestinal ischemia can
have mucous and bloody stools. In addition, this pathophysiolog-
ical event might lead to further complications, since loss of the
mucus layer in the small intestine has been linked to decreased
protection to intraluminal bacteria and pancreatic enzymes. [23]
This increases tissue damage and bacterial translocation to the
internal milieu. [24] Together, both death cells and intruding
pathogens are likely to cause an inflammatory response following
intestinal IR, characterized by neutrophil influx and expression of
inflammatory cytokines. [14,21,25,26] This will eventually also
trigger inflammation in distant organs including the lung, which
highly contributes to intestinal IR-induced morbidity and mortal-
ity. [4,5,6,27].
Unfortunately, there are at present only limited possibilities to
prevent reperfusion-induced inflammatory complications with the
current treatment modalities. It is therefore tempting to speculate
on possible future preventive strategies using the VCE. For
example, recent evidence shows that endoplasmic reticulum (ER)
stress is an important pathophysiological phenomenon in human
intestinal IR, associated with aforementioned Paneth cell apoptosis
and increased bacterial translocation and inflammation. [14]
Topical intraluminal treatment with agents that alleviate ER
stress, including the FDA approved tauroursodeoxycholic acid
(TUDCA) and 4-phenyl butyrate acid (PBA), could be a potential
future preventive of therapeutic strategy to reduce IR-induced
complications. In addition, intraluminal release of anti-inflamma-
tory agents could dampen the local inflammatory response as well
as the subsequent tissue damage, thereby preventing bacterial
translocation, excessive inflammation, and potentially also distant
organ injury. Topical treatment using VCE is feasible in the
foreseeable future, since new technology has been developed that
allows maneuvering of the capsules in the intestine (via magnets or
propellers). [28,29] This can halt the capsule at a desired spot to
release topical agents. In addition, such techniques could prevent
Figure 3. Concordance between endoscopic and histological appearance. (A) Normal endoscopic view and histological appearance. (B)
At 30 minutes of ischemia, subepithelial spaces appear (asterisks), indicating retraction of the basement membrane. This relates to the pale
discoloration of mucosa in the endoscopic view. (C) At 60 minutes of ischemia, breaches in the epithelial lining can be observed (arrowhead),
which relate to the appearance of punctate lesions in the endoscopic view (white arrow). (D) At 30 minutes of reperfusion, hemorrhage and
shedding of IR-damaged epithelial cells becomes evident in both histological view (right panel: red arrowhead and black arrowhead,
respectively), and endoscopic view (left panel: black arrow and white arrow, respectively). (E) At 60 minutes of reperfusion, villus atrophy in
observed in conjunction with gaps in the epithelial lining and luminal debris. This relates to the loss of villous structure in endoscopic view, and
the ‘white clouds’ of intraluminal debris.
doi:10.1371/journal.pone.0039638.g003
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consequence of pathological situations, including intestinal ische-
mia.
In conclusion, we have provided a first unique, real-time in vivo
view of the early mucosal changes during IR of the human small
intestine. Future studies should be directed at evaluating the
usefulness of VCE as part of the diagnostic workup of patients
suspected of splanchnic ischemia. Moreover, VCE might be used
to topically treat IR-induced damage, or limit reperfusion-induced
damage after restoration of the blood flow.
Acknowledgments
The authors wish to thank Ton Mestrom and the endoscopy nurses, as well
as the surgical team for the excellent surgical assistance.
Author Contributions
Conceived and designed the experiments: JG WB CHCD. Performed the
experiments: JG WH RvD CHCD. Analyzed the data: JG WH.
Contributed reagents/materials/analysis tools: AM WB CHCD. Wrote
the paper: JG. Critical revision of the manuscript for important intellectual
content: JG WH AM RvD WB CHCD.
References
1. (2000) American Gastroenterological Association Medical Position Statement:
guidelines on intestinal ischemia. Gastroenterology 118: 951–953.
2. Oldenburg WA, Lau LL, Rodenberg TJ, Edmonds HJ, Burger CD (2004) Acute
mesenteric ischemia: a clinical review. Arch Intern Med 164: 1054–1062.
3. Derikx JP, Poeze M, van Bijnen AA, Buurman WA, Heineman E (2007)
Evidence for intestinal and liver epithelial cell injury in the early phase of sepsis.
Shock 28: 544–548.
4. Fink MP, Delude RL (2005) Epithelial barrier dysfunction: a unifying theme to
explain the pathogenesis of multiple organ dysfunction at the cellular level. Crit
Care Clin 21: 177–196.
5. Reino DC, Pisarenko V, Palange D, Doucet D, Bonitz RP, et al. (2011) Trauma
hemorrhagic shock-induced lung injury involves a gut-lymph-induced TLR4
pathway in mice. PLoS ONE 6: e14829.
6. Feinman R, Deitch EA, Watkins AC, Abungu B, Colorado I, et al. (2010) HIF-1
mediates pathogenic inflammatory responses to intestinal ischemia-reperfusion
injury. Am J Physiol Gastrointest Liver Physiol 299: G833–843.
7. Kougias P, Lau D, El Sayed HF, Zhou W, Huynh TT, et al. (2007)
Determinants of mortality and treatment outcome following surgical interven-
tions for acute mesenteric ischemia. J Vasc Surg 46: 467–474.
8. Kozuch PL, Brandt LJ (2005) Review article: diagnosis and management of
mesenteric ischaemia with an emphasis on pharmacotherapy. Aliment
Pharmacol Ther 21: 201–215.
9. Van Noord D, Sana A, Benaron DA, Pattynama PM, Verhagen HJ, et al. (2011)
Endoscopic visible light spectroscopy: a new, minimally invasive technique to
diagnose chronic GI ischemia. Gastrointest Endosc 73: 291–298.
10. Mensink PB, Moons LM, Kuipers EJ (2011) Chronic gastrointestinal ischaemia:
shifting paradigms. Gut 60: 722–737.
11. Kurland B, Brandt LJ, Delany HM (1992) Diagnostic tests for intestinal
ischemia. Surg Clin North Am 72: 85–105.
12. Iddan G, Meron G, Glukhovsky A, Swain P (2000) Wireless capsule endoscopy.
Nature 405: 417.
13. Derikx JP, Matthijsen RA, de Bruine AP, van Dam RM, Buurman WA, et al.
(2009) A New Model to Study Intestinal Ischemia-Reperfusion Damage in Man.
J Surg Res 166: 222–226.
14. Grootjans J, Hodin CM, de Haan JJ, Derikx JP, Rouschop KM, et al. (2011)
Level of activation of the unfolded protein response correlates with paneth cell
apoptosis in human small intestine exposed to ischemia/reperfusion. Gastroen-
terology 140: 529–539 e523.
15. Grootjans J, Thuijls G, Derikx JP, van Dam RM, Dejong CH, et al. (2011)
Rapid lamina propria retraction and zipper-like constriction of the epithelium
preserves the epithelial lining in human small intestine exposed to ischaemia-
reperfusion. J Pathol 224: 411–419.
16. Derikx JP, Matthijsen RA, de Bruine AP, van Bijnen AA, Heineman E, et al.
(2008) Rapid reversal of human intestinal ischemia-reperfusion induced damage
by shedding of injured enterocytes and reepithelialisation. PLoS ONE 3: e3428.
17. Sharma VK (2009) The future is wireless: advances in wireless diagnostic and
therapeutic technologies in gastroenterology. Gastroenterology 137: 434–439.
18. Liatsos C, Goulas S, Karagiannis S, Patelaros E, Sabaziotis D, et al. (2005)
Diagnosis of small-bowel ischemic necrosis by capsule endoscopy. Gastrointest
Endosc 62: 439–440; discussion 440.
19. Liatsos C, Kyriakos N, Vasilakos I, Veloudis G, Patrikos D, et al. (2010) Diffuse
enteric ischemia due to Wegener’s granulomatosis revealed by capsule
endoscopy (with video). Endoscopy 42 Suppl 2: E39.
20. Parks DA, Granger DN (1986) Contributions of ischemia and reperfusion to
mucosal lesion formation. Am J Physiol 250: G749–753.
21. Grootjans J, Lenaerts K, Derikx JP, Matthijsen RA, de Bruine AP, et al. (2010)
Human intestinal ischemia-reperfusion-induced inflammation characterized:
experiences from a new translational model. Am J Pathol 176: 2283–2291.
22. Grootjans J, Hundscheid IH, Lenaerts K, Boonen B, Renes IB, et al. (2012)
Ischaemia-induced mucus barrier loss and bacterial penetration are rapidly
counteracted by increased goblet cell secretory activity in human and rat colon.
Gut, In press.
23. Chang M, Kistler EB, Schmid-Schonbein GW (2012) Disruption of the mucosal
barrier during gut ischemia allows entry of digestive enzymes into the intestinal
wall. Shock 37: 297–305.
24. Qin X, Sheth SU, Sharpe SM, Dong W, Lu Q, et al. (2011) The mucus layer is
critical in protecting against ischemia-reperfusion-mediated gut injury and in the
restitution of gut barrier function. Shock 35: 275–281.
25. Chen Y, Lui VC, Rooijen NV, Tam PK (2004) Depletion of intestinal resident
macrophages prevents ischaemia reperfusion injury in gut. Gut 53: 1772–1780.
26. Homer-Vanniasinkam S, Crinnion JN, Gough MJ (1997) Post-ischaemic organ
dysfunction: a review. Eur J Vasc Endovasc Surg 14: 195–203.
27. Breithaupt-Faloppa AC, Vitoretti LB, Cavriani G, Lino-Dos-Santos-Franco A,
Sudo-Hayashi LS, et al. (2011) Intestinal Lymph-Borne Factors Induce Lung
Release of Inflammatory Mediators and Expression of Adhesion Molecules After
an Intestinal Ischemic Insult. J Surg Res.
28. Swain P, Toor A, Volke F, Keller J, Gerber J, et al. (2010) Remote magnetic
manipulation of a wireless capsule endoscope in the esophagus and stomach of
humans (with videos). Gastrointest Endosc 71: 1290–1293.
29. Kim HM, Yang S, Kim J, Park S, Cho JH, et al. (2010) Active locomotion of a
paddling-based capsule endoscope in an in vitro and in vivo experiment (with
videos). Gastrointest Endosc 72: 381–387.
A New In Vivo Perspective on Human Intestinal IR
PLoS ONE | www.plosone.org 5 June 2012 | Volume 7 | Issue 6 | e39638